CSL CEO Brian McNamee On Being Australia's Only Homegrown MNC: An Interview With PharmAsia News (Part 2 of 2)
This article was originally published in PharmAsia News
Executive Summary
[Editor's note: This is part two of a two-part interview. Part one appeared in PharmAsia News, June 1, 2009.]
You may also be interested in...
Analysts Mixed As Australia’s CSL Moves To Settle U.S. Price Fixing Case
Australia’s CSL has probably made the right decision to settle a price-fixing lawsuit in the United States and thereby avoid a protracted legal battle that could have seen further substantial legal costs even if it eventually won. But the proposed settlement has some analysts concerned the legal basis for the lawsuit was thin as it stemmed from regulatory questions raised in a failed industry merger.
First Out Of The Gate, CSL Begins Adult Trials Of H1N1 Flu Vaccine
PERTH, Australia - Melbourne-headquartered CSL Limited will begin clinical trials of its H1N1 influenza vaccine in healthy adults ages 18 to 64 July 22, and pediatric trials will commence Aug. 1, CSL said
First Out Of The Gate, CSL Begins Adult Trials Of H1N1 Flu Vaccine
PERTH, Australia - Melbourne-headquartered CSL Limited will begin clinical trials of its H1N1 influenza vaccine in healthy adults ages 18 to 64 July 22, and pediatric trials will commence Aug. 1, CSL said